Kung Che-Pei, Leu Julia I-Ju, Basu Subhasree, Khaku Sakina, Anokye-Danso Frederick, Liu Qin, George Donna L, Ahima Rexford S, Murphy Maureen E
Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA 19104, USA.
Department of Genetics, The Perelman School at the University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Cell Rep. 2016 Mar 15;14(10):2413-25. doi: 10.1016/j.celrep.2016.02.037. Epub 2016 Mar 3.
p53 is well known for its tumor suppressor role, but this protein also has a poorly understood role in the regulation of metabolism. Human studies have implicated a common polymorphism at codon 72 of p53 in diabetic and pre-diabetic phenotypes. To understand this role, we utilized a humanized mouse model of the p53 codon 72 variants and monitored these mice following challenge with a high-fat diet (HFD). Mice with the arginine 72 (R72) variant of p53 developed more-severe obesity and glucose intolerance on a HFD, compared to mice with the proline 72 variant (P72). R72 mice developed insulin resistance, islet hypertrophy, increased infiltration of immune cells, and fatty liver disease. Gene expression analyses and studies with small-molecule inhibitors indicate that the p53 target genes Tnf and Npc1l1 underlie this phenotype. These results shed light on the role of p53 in obesity, metabolism, and inflammation.
p53因其肿瘤抑制作用而广为人知,但这种蛋白质在代谢调节中的作用却鲜为人知。人体研究表明,p53第72位密码子的常见多态性与糖尿病和糖尿病前期表型有关。为了解这一作用,我们利用了p53第72位密码子变体的人源化小鼠模型,并在高脂饮食(HFD)刺激后对这些小鼠进行监测。与携带脯氨酸72变体(P72)的小鼠相比,携带p53精氨酸72(R72)变体的小鼠在高脂饮食下出现了更严重的肥胖和葡萄糖不耐受。R72小鼠出现了胰岛素抵抗、胰岛肥大、免疫细胞浸润增加和脂肪肝疾病。基因表达分析和小分子抑制剂研究表明,p53靶基因Tnf和Npc1l1是这一表型的基础。这些结果揭示了p53在肥胖、代谢和炎症中的作用。